Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: What we do and do not know
Authors:
Open Access
- 27 April 2015
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 50 (8) , 1030-1036
Abstract
Human herpesvirus-6 (HHV-6) encephalitis following allogeneic hematopoietic cell transplantation is a serious and often fatal complication accompanying reactivation of HHV-6B. Incidence varies among studies, but is reportedly 0–11.6% after bone marrow or PBSC transplantation and 4.9–21.4% after umbilical cord blood transplantation, typically around 2–6 weeks post transplant. Symptoms are characterized by memory loss, loss of consciousness and seizures. Magnetic resonance imaging (MRI) typically shows bilateral signal abnormalities in the limbic system. This complication is considered to represent acute encephalitis caused by direct virally induced damage to the central nervous system, but our understanding of the etiologies and pathogenesis is still limited. The mortality rate attributable to this pathology remains high, and survivors are often left with serious sequelae such as impaired memory and epilepsy. Despite the poor prognosis, no validated treatments or preventative measures have been established. Establishment of preventative strategies represents an important challenge. This article reviews the current knowledge of the clinical features, incidence, pathogenesis and treatment of HHV-6 encephalitis, and discusses issues needing clarification in the future to overcome this serious complication.Keywords
This publication has 90 references indexed in Scilit:
- CD134 is a cellular receptor specific for human herpesvirus-6B entryProceedings of the National Academy of Sciences, 2013
- First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA VirusesAntimicrobial Agents and Chemotherapy, 2012
- Chromosomally integrated human herpesvirus 6: questions and answersReviews in Medical Virology, 2011
- Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary?Transplantation and Cellular Therapy, 2011
- HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipientsBlood, 2011
- A case of pneumonitis and encephalitis associated with human herpesvirus 6 (HHV-6) infection after bone marrow transplantationBritish Journal of Radiology, 2010
- Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnetTransplant Infectious Disease, 2010
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Chromosomal Integration of Human Herpesvirus 6 Is the Major Mode of Congenital Human Herpesvirus 6 InfectionPediatrics, 2008
- Human Herpesvirus 6 Chromosomal Integration in Immunocompetent Patients Results in High Levels of Viral DNA in Blood, Sera, and Hair FolliclesJournal of Clinical Microbiology, 2006